Nannini
Carl Nannini, Grand Rapids, MI US
Patent application number | Description | Published |
---|---|---|
20110171319 | NUTRITIONAL COMPOSITION MADE USING ISOLATED ORGANIC MATTER - Nutritional compositions, formulations, and intermediates are provided which may be utilized to formulate various sweeteners and other products. The formulations described herein are made from constituents found in soils or fossilized soils. | 07-14-2011 |
20130236606 | NUTRITIONAL COMPOSITION MADE USING ISOLATED ORGANIC MATTER - Nutritional compositions, formulations, and intermediates are provided which may be utilized to formulate various sweeteners and other products. The formulations described herein are made from constituents found in soils or fossilized soils. | 09-12-2013 |
Michael J. Nannini, Sparks, NV US
Patent application number | Description | Published |
---|---|---|
20090011240 | CRYSTALLINE SILICA-FREE DIATOMACEOUS EARTH FILTER AIDS AND METHODS OF MANUFACTURING THE SAME - A method of producing a range of diatomaceous earth filter aids having selectable permeabilities and less than about 1 percent by weight total crystalline silica. The method includes milling diatomaceous earth ore to a size range of between about 100 micrometers and about 1400 micrometers; calcining the milled diatomaceous earth in a calciner; and milling the calcined diatomaceous earth in an adjustable milling and classification system to produce diatomaceous earth filter aids. Systems to implement such methods and compositions produced by such methods are also described. | 01-08-2009 |
20090181848 | CRYSTALLINE SILICA-FREE DIATOMACEOUS EARTH BLENDED FILTER AIDS AND METHODS OF MANUFACTURING THE SAME - A method of producing a range of diatomaceous earth blended filter aids having selectable permeabilities and less than about 1 percent by weight total of crystalline silica and less than about 0.1% by weight total of respirable crystalline silica. The method includes milling diatomaceous earth ore to a size range of between about 100 micrometers and about 1400 micrometers; calcining the milled diatomaceous earth in a calciner; milling the calcined diatomaceous earth in an adjustable milling and classification system to produce diatomaceous earth filter aids, and blending the diatomaceous earth with expanded perlite to form a low bulk density and low solubility filter aid. | 07-16-2009 |
Michael Joseph Nannini, Sparks, NV US
Patent application number | Description | Published |
---|---|---|
20140171305 | Diatomaceous Earth Filter Aid Containing a Low Crystalline Silica Content - A diatomaceous earth product with low crystalline silica content after at least one calcination step of between about 927° C. (1700° F.) and about 1149° C. (2100° F.) is disclosed. The product comprises natural diatomaceous earth and at least one binding agent comprising potassium silicate. Further the product comprises no more than about 4.0 wt % of crystalline silica and has a permeability in the range of about 0.3 darcy to greater than about 20 darcy. A process for making such diatomaceous earth product with a low crystalline silica content is disclosed. Moreover, a diatomaceous earth filter aid comprising such a diatomaceous earth product is disclosed. | 06-19-2014 |
Michelle Nannini, South San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20140155372 | COMBINATIONS OF AKT AND MEK INHIBITOR COMPOUNDS, AND METHODS OF USE - The invention provides combinations comprising a) compound of formula I: (formula I), or a pharmaceutically acceptable salt thereof; and another agent selected from GDC-0973, PD-0325901, or a pharmaceutically acceptable salt thereof. The combinations are particularly useful for treating hyperproliferative disorders, such as cancer. | 06-05-2014 |
20140221386 | COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ERLOTINIB, AND METHODS OF USE - The invention provides A combination of a) a compound of Formula (I) or a pharmaceutically acceptable salt thereof; and b) erlotinib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer. | 08-07-2014 |
20140256691 | COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ABIRATERONE, AND METHODS OF USE - The invention provides a combination of a) a compound of Formula (Ia): or a pharmaceutically acceptable salt thereof, and b) abiraterone or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer. | 09-11-2014 |
20150064171 | COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND CHEMOTHERAEPTUC AGENTS, AND METHODS OF USE - The invention provides combinations comprising a) compound of formula (I) or a pharmaceutically acceptable salt thereof wherein R | 03-05-2015 |